+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors



Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors



Structure 7(1): 81-89



Trypanothione reductase (TR) helps to maintain an intracellular reducing environment in trypanosomatids, a group of protozoan parasites that afflict humans and livestock in tropical areas. This protective function is achieved via reduction of polyamine-glutathione conjugates, in particular trypanothione. TR has been validated as a chemotherapeutic target by molecular genetics methods. To assist the development of new therapeutics, we have characterised the structure of TR from the pathogen Trypanosoma cruzi complexed with the substrate trypanothione and have used the structure to guide database searches and molecular modelling studies. The TR-trypanothione-disulfide structure has been determined to 2.4 A resolution. The chemical interactions involved in enzyme recognition and binding of substrate can be inferred from this structure. Comparisons with the related mammalian enzyme, glutathione reductase, explain why each enzyme is so specific for its own substrate. A CH***O hydrogen bond can occur between the active-site histidine and a carbonyl of the substrate. This interaction contributes to enzyme specificity and mechanism by producing an electronic induced fit when substrate binds. Database searches and molecular modelling using the substrate as a template and the active site as receptor have identified a class of cyclic-polyamine natural products that are novel TR inhibitors. The structure of the TR-trypanothione enzyme-substrate complex provides details of a potentially valuable drug target. This information has helped to identify a new class of enzyme inhibitors as novel lead compounds worthy of further development in the search for improved medicines to treat a range of parasitic infections.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045677287

Download citation: RISBibTeXText

PMID: 10368274

DOI: 10.1016/s0969-2126(99)80011-2


Related references

Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex. Proteins 24(1): 73-80, 1996

The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution. Protein Science 5(1): 52-61, 1996

A computer-built three-dimensional structure of trypanothione reductase from Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz Rio de Janeiro 87(Suppl. 2): 136, 1992

Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi. Bioorganic and Medicinal Chemistry Letters 8(10): 1175-1180, 1998

The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state. Proteins 18(2): 161-173, 1994

Trypanosoma cruzi trypanothione reductase. Crystallization, unit cell dimensions and structure solution. Journal of Molecular Biology 232(4): 1217-1220, 1993

Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: kinetic studies and structure-activity relationships. Journal of Medicinal Chemistry 42(26): 5448-5454, 1999

The 3-dimensional structure of trypanothione reductase from Trypanosoma cruzi as a basis for drug design against Chagas disease. Yagi, K Flavins and flavoproteins 1993 545-555, 1994

Inhibition of Trypanosoma cruzi trypanothione reductase by crystal violet. Molecular and Biochemical Parasitology 67(2): 313-320, 1994

Arylfurans as potential trypanosoma cruzi trypanothione reductase inhibitors. Memorias do Instituto Oswaldo Cruz 101(2): 169-173, 2006

Synthesis of non reducible inhibitors for trypanothione reductase from Trypanosoma cruzi. Bioorganic & Medicinal Chemistry Letters 3(10): 1971-1976, 1993

Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design. European Journal of Medicinal Chemistry 39(5): 421-431, 2004

Platinum complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase. Journal of Medicinal Chemistry 43(25): 4812-4821, 2000

N- substituted polyamine derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase. Abstracts of Papers American Chemical Society 225(1-2): CHED 362, 2003

New potent inhibitors of trypanothione reductase from Trypanosoma cruzi in the 2-aminodiphenylsulfide series. European Journal of Medicinal Chemistry 32(1): 39-52, 1997